BioTime Inc (BTX) Drops 7.89% on January 13

Equities Staff |

BioTime Inc (BTX) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 7.89% to $2.57, a loss of $-0.22 per share. Starting at an opening price of $2.80 a share, the stock traded between $2.47 and $2.83 over the course of the trading day. Volume was 336,101 shares over 919 trades, against an average daily volume of 311,856 shares and a total float of 94.89 million.

The losses send BioTime Inc down to a market cap of $243.88 million. In the last year, BioTime Inc has traded between $5.95 and $2.20, and its 50-day SMA is currently $3.38 and 200-day SMA is $3.60.

BioTime Inc is a biotechnology company. The Company is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology.

BioTime Inc is based out of Alameda, CA and has some 120 employees. Its CEO is Michael D. West / Aditya Mohanty / Pedro Lichtinger.

For a complete fundamental analysis analysis of BioTime Inc, check out Equities.com’s Stock Valuation Analysis report for BTX. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IGEN Networks Corp.

iGen Networks Corp is engaged in investing in and managing for growth private high-tech companies that offer products and services in the domains of wireless broadband, software as a service,…

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…